Aaron M Wieland, MD
- Section of Head and Neck Surgical Oncology
- Division of Otolaryngology-Head & Neck Surgery
Office: (608) 265-8207
- Clinical Appointments: (608) 263-6190
600 Highland Ave
BX7375 Clinical Science Center-K4
Madison, WI 53792-3284
- MD, Harvard Medical School, Boston, MA, 2005
- Residency in Otolaryngology - Head & Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, MA, 2010
- Fellowship in Head and Neck Surgical Oncology and Microvascular Reconstruction, University of Wisconsin Hospital and Clinics, Madison, WI, 2012
Dr. Wieland is certified by the American Board of Otolaryngology. He specializes in treatment of head and neck cancer, voice and swallowing disorders, trauma, reconstruction, and robotic surgery. He is chief of the otolaryngology service at the William S. Middleton Memorial Veterans Hospital.
Dr. Wieland provides a wide range of services including Airway Dilation, Airway Reconstruction, Endoscopic Partial Laryngectomy, Esophageal Dilation, Free Flap, Free Tissue Transfer, Functional Neck Dissection, Laryngeal Surgery, Laser Procedures, Leukoplakia Laser Treatment, Maxilofacial Trauma Repair, Open Partial Laryngectomy, Repairs Of Skull Base Defects, Skin Cancer Reconstruction, Skull Base Surgery, Total Laryngectomy, Tracheostomy, Transnasal Esophagoscopy (TNE), Transoral Robotic Surgery.
Reconstruction After Skin Cancer Resection of the Head and Neck.
Zimmer DI, Wieland AM, Ku JA
Otolaryngol Clin North Am 2023 Aug; 56(4): 779-790
[PubMed ID: 37277301]
Functional Outcomes After Transoral Plus Lateral Pharyngotomy Approach for Advanced Oral and Oropharyngeal Tumors.
Colevas SM, Merfeld EC, Pflum ZE, Gessert TG, Wieland AM, Glazer TA, Burr AR, Harari PM, Hartig GK
OTO Open 2023; 7(1): e35
[PubMed ID: 36998565]
Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes.
Merfeld EC, Witek ME, Francis DM, Burr AR, Wallace CR, Kuczmarska-Haas A, Lamichhane N, Kimple RJ, Glazer TA, Wieland AM, McCulloch TM, Hartig GK, Harari PM
Pract Radiat Oncol 2023; 13(4): 340-345
[PubMed ID: 36709044]
Patterns of failure for hypopharynx cancer patients treated with limited high-dose radiotherapy treatment volumes.
Burr A, Harari P, Wieland A, Kimple R, Hartig G, Witek M
Radiat Oncol J 2022 Dec; 40(4): 225-231
[PubMed ID: 36456541]
Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients With Low-risk and Intermediate-risk p16-positive Oropharynx Cancer.
Witek ME, Kimple RJ, Avey GD, Burr AR, Chandereng T, Yu M, Hu R, Wieland AM, Labby ZE, Bruce JY, Brower JV, Hartig GK, Harari PM
Am J Clin Oncol 2022 May 01; 45(5): 202-207
[PubMed ID: 35446279]